Account
Inquiry
Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist currently being studied for type 2 diabetes treatment and weight management applications. Our tirzepatide for sale meets strict pharmaceutical grade standards with 99.9% purity.
This synthetic peptide demonstrates superior efficacy in glucose control and weight reduction compared to single agonists. The molecular structure features a PEG-modified lysine side chain that enhances water solubility while maintaining biological activity. Tirzepatide for sale is presented as a white lyophilized powder in sterile vials.
Clinical studies have shown significant weight loss results with tirzepatide, with average reductions of 15-20.9% body weight at different dosage levels over 72 weeks. The compound has received FDA Fast Track designation for obesity treatment applications.
Our tirzepatide for sale is supplied in research quantities with each vial containing 10mg of active peptide. The product is packaged in boxes of 10 vials with appropriate labeling. This product is intended for laboratory research purposes only and not for human consumption.
Proper storage is essential for maintaining peptide integrity. We recommend storing tirzepatide in a cool, dry environment protected from light. Avoid repeated freeze-thaw cycles and prolonged exposure to air or solution.
For research institutions and pharmaceutical developers, we offer custom synthesis services and bulk quantities of tirzepatide for sale. Our manufacturing facilities maintain strict quality control standards to ensure batch-to-batch consistency.
